HX575 epoetin alfa

epoetin alfa · Sandoz

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for HX575 epoetin alfa, covering 2017-05-12 to 2017-06-19. Get the full timeline:

Most recent: Clinical Trial Update: HX575 Epoetin Alfa Subcutaneously (s.c.) in Chronic Kidney Disease (CKD) [Phase 3]